Balyasny Asset Management LLC Aerie Pharmaceuticals Inc Transaction History

Balyasny Asset Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.95 - $9.16 $256,489 - $474,634	51,816 New	51,816 $389,000
Q4 2021 Feb 14, 2022	SELL	$7.02 - $13.33 $1.85 Million - $3.5 Million	-262,835 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.32 - $16.63 $2.98 Million - $4.37 Million	262,835 New	262,835 $3 Million
Q2 2020 Aug 14, 2020	SELL	$12.0 - $16.13 $2.37 Million - $3.19 Million	-197,844 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $2.34 Million - $5.05 Million	197,844 New	197,844 $2.67 Million
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $4.52 Million - $6.4 Million	-255,164 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $4.7 Million - $7.14 Million	255,164 New	255,164 $4.9 Million
Q1 2019 May 15, 2019	SELL	$36.32 - $49.25 $1.29 Million - $1.75 Million	-35,611 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$33.0 - $60.04 $9.46 Million - $17.2 Million	-286,572 Reduced 88.95%	35,611 $1.29 Million
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $3.54 Million - $4.66 Million	-63,059 Reduced 16.37%	322,183 $19.8 Million
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $15.7 Million - $23.1 Million	328,442 Added 578.24%	385,242 $26 Million
Q1 2018 May 15, 2018	SELL	$51.15 - $61.0 $1.29 Million - $1.54 Million	-25,189 Reduced 30.72%	56,800 $3.08 Million
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $4.17 Million - $5.34 Million	81,989	81,989 $4.9 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.